Bruker Daltonics Introduces BioThreat Profiler, a Research Tool for Biomarker-based Identification of Biological Warfare Agents
Bruker Daltonics Inc., an operating company of Bruker BioSciences Corporation, announces the BioThreat Profiler(TM), a novel approach for lab-based research on biomarkers for the identification of biological warfare agents (BWAs) using MALDI-TOF (Matrix Assisted Laser Desorption Ionization-Time of Flight) mass spectrometry. The rapidly increasing demands on homeland security have led to the urgent need for additional bio-security research, and for fast and reliable confirmatory identification of known biological agents, as well as novel strains and mutants in a laboratory setting.
Based on Bruker Daltonics’ experience in the life-science research market and in clinical biomarker discovery systems, the outstanding performance of our MALDI-TOF(/TOF) mass spectrometers with specialized software meets the requirements of a research system for biomarker discovery for fast and reliable identification of suspect biological species, and for potential differentiation of related strains and mutants. The BioThreat Profiler is being introduced today at the 8th International Symposium on Protection against Chemical and Biological Warfare Agents in Gothenburg.
The BioThreat Profiler system is applicable to bacteria, spores, fungi and toxins, i.e. also to biological threats that do not contain any DNA or RNA. Bruker Daltonics’ use of a novel biomarker database for the identification of micro-organism and other BWAs leads to a powerful approach for bio-security research, and for lab-based species and strain-specific identification and confirmatory analysis.
ABOUT BRUKER BIOSCIENCES
Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker Daltonics also offers a broad line of nuclear, biological and chemical detection products for defense and homeland security. For more information, please visit www.bruker-biosciences.com .
CAUTIONARY STATEMENT
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company’s products, changes in governmental regulations, capital spending and government funding policies, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2003, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements.
